REG Price sensitive 23 Feb 2026, 8:44 AM

REG Investor Presentation 1H FY26

Regis Healthcare Ltd

REG Investor Presentation 1H FY26

Key points

  • Revenue from services up 18.4% to $667.7 million
  • Underlying EBITDA up 3.7% to $70.6 million
  • Net operating cash flow up 39.9% to $291.7 million

Full summary

Regis Healthcare reported a solid set of results for 1H FY26, with revenue from services increasing 18.4% to $667.7 million, driven by higher average occupancy, AN-ACC and hotelling supplement increases, and contributions from recent acquisitions. Underlying EBITDA grew 3.7% to $70.6 million, while underlying NPAT was up 0.1% to $29.7 million. Net operating cash flow increased 39.9% to $291.7 million, supported by a $178.5 million net RAD cash inflow. The company declared a fully-franked interim dividend of 9.0 cents per share, the first since FY19. Operationally, Regis achieved a mature homes average occupancy of 96.0% and improved its average overall star rating to 3.92. The company completed the acquisitions of Rockpool (4 homes, 600 beds) and OC Health (2 homes, 230 beds) during the period, adding 830 beds to its portfolio. Regis also continued to invest in greenfield developments and refurbishments, with capital expenditure of $102.1 million. Looking ahead, the company remains focused on its growth strategy, with an active M&A pipeline and ongoing investment in its existing portfolio.

Guidance

Regis did not provide any high-importance, price-sensitive forward-looking financial metrics in the announcement.

Summary generated by a large language model. Please interpret with care.

Sign in for more about this company, including guidance changes and other insights.
Sign in